A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Participants

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

March 5, 2020

Study Completion Date

March 19, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-418

TAK-418 orally.

DRUG

[18F]MNI-1054 (radiotracer)

\[18F\]MNI-1054 injection.

Trial Locations (1)

Invicro, A Konica Minolta Company, New Haven